Restriction Endonucleases Products: Restriction Enzymes are Used as Key Reagents in Process of DNA Sequencing

Restriction enzymes or restriction endonucleases (RE) are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. These enzymes cut the deoxyribonucleotide (DNA) at specific nucleotide sequences and the biological function of these enzymes is to protect cells from foreign DNA . Nomeclature for these enzymes is based on the first letter of the genus followed by first two letters of the species and name of the bacteria of origin. These enzymes find applications in various research activities involving molecular biology techniques.

For instance, these enzymes are used as key reagents in processes such as restriction fragment length polymorphism (RFLP), genomic mapping, several recombinant procedures and DNA sequencing. There are four classes of restriction endonucleases namely types I, II, III and IV of which class II enzymes are the most popular and more useful as compared to others. The reason being the specific determination of the DNA sequences and generate termini with 5’ phosphate and 3’ hydroxyl groups and are capable of recognizing non-palindromic sequences. There has been continuous evolution of the new prototype activities that render continuous updates about new recognition sites along with the commercial availability. REBASE is such one database that provides monthly updates about the above mentioned factors.

Till date more than 10,000 bacteria are screened for the presence of restriction enzymes and currently there are more than 2,500 restriction enzymes have been discovered along with over 250 distinct specificities in sequences. The microorganisms that produce RE also produce DNA methyltransferases and this feature protects their own DNA from cleavage.

These enzymes are used in conventional cloning, deciphering epigenetic modifications, construction of DNA libraries and in vivo gene editing. The market for restriction endonucleases can be segmented by various types that are available commercially and the respective application areas. Companies such as New England Biolabs, Inc. and Thermo Fisher Scientific engage in development and marketing of various types of restriction enzymes (A-Z). For instance, New England Biolabs, Inc. offers restriction enzymes in variable sizes such as 500 and 2,500 units. These units are priced at USD 57.00 for one unit. In addition, Thermo Fisher Scientific also offers these by FastDigest (176) brand and Conventional enzymes.

Future Market Projections for Restriction Enzymes: http://bit.ly/2fGJ2Tc

Factors such as regulatory policies and product approvals govern the market growth. Furthermore, it can be classifies by the applications and end users. Pharmaceutical and biotechnology companies along with academic research institutes utilize these REs in various activities. Geographically, North America and Europe are the highest revenue generators in this market owing to increasing research and development activities followed by the presence of manufacturers in these regions. On the other hand Asia Pacific and Rest of the World (RoW) regions present lucrative opportunities for the growth of this market due to increasing research projects funding by the respective governments followed by increasing commercial production of these enzymes.

 There is a tremendous growth potential in acceptance of these enzymes owing to increasing implementation of molecular biology techniques and processes followed by increasing research and development activities making use of these enzymes. On the other hand, factors such as high cost of downstream activities coupled with variable reliability and accuracy of these enzymes are some factors that might restrain the market growth. Agilent Technologies, Inc., Genetix Biotech Asia Pvt. Ltd., New England Biolabs, Inc., ThermoFisher Scientific, Inc., and Promega Corporation are some of the key market players operating in this market.

Nanoparticle Size Analysis Instruments – In Life-Science Industry due to its high accuracy, it is Used to Measure Particle Size for Analytical and Scientific Purpose

Nano-particles are defined as small objects, having nanometer size in the range of 1-100 nano-meters. These particles can be divided into different types such as ultrafine particles, coarse particles and fine particles according to their diameters. Nano-particle based analysis instrument are commonly used to detect the diameter of the nano-particles. There are two methods commonly used for detecting or analyzing nano-particle size namely by microscopic techniques and by utilizing relation between particle behavior and its size. The particle size analysis of nano-particles can be determined using large number of commercially available instruments such as flow cytometry, microscopic techniques, electron imaging techniques and others. The nano-particle size analysis instruments are widely used in life-science industry due to its high accuracy to measure particle size for analytical and scientific purpose.

One of the key factors driving nano-particle size analysis instrumentation in the life sciences market is the advancement in technology and introduction of novel methods for nano particle analysis by key market players. For example, NanoSight provides Nanoparticle Tracking Analysis (NTA) technique, unique method for analyzing nano particles in liquid medium. This technique is featured with unique single particle detection system that allows the measurement of particles in the range of 10-2000 nm in liquid suspension. Thus, advancement and introduction of new methods will boost the uptake of nano-particle size analysis instrumentation hence drives the market growth. In addition, several advantages of these technologies such as accurate and reliable particle size analysis, requirement of less product volume and compliance with regulatory requirement will further augment the market growth of global nano-particle size analysis instrumentation in the life sciences. However, high cost of the instrument or technologies will restrain the market growth in near future.

The market of Nano-particle Size Analysis Instrumentation in the Life Sciences can be segmented on the basis of:

By Technologies

> Electron Imaging Technology

> Flow Cytometry

>Microscope Technology

>> Atomic Focus Microscope

>> Scanning Tunneling Electron Microscope

>> Cryo-Electron Tomography Microscopy

>> Scanning Tunneling Microscopy

> Ultra-Centrifugation

> Gel Permeation Chromatography

> Stem Instrument

> Others

Get the Future Market Forecast of Nano-Particle Size Analysis Instrumentation in the Life Sciences at: http://bit.ly/2fwo1PR

By End-Users

> Biopharmaceutical Industries

> Life Sciences Industries

> Others

Geographically, North America dominates the global nano-particle size analysis instrumentation in the life sciences market. Technological advancement coupled with consistent efforts of key players to develop new products will drive the growth of this market in North America. Europe is considered as the second largest market of nano-particle size analysis instrumentation in the life sciences. Presence of large number of domiciled key players and rising demand of nano particle size instrumentation will stimulate the market growth in this region. Launch of novel instruments with improved accuracy that enables to provide effective analysis of nano-particle will boost the demand of this market in Asia-Pacific. In addition, developing healthcare infrastructure coupled with positive government initiatives will further stimulate the growth of nano-particle size analysis instrumentation in the life sciences market in Asia-Pacific.

Some of the key players in the global nano-particle size analysis instrumentation in the life sciences market comprises Agilent Technologies, Inc., ASPEX Corporation, Asylum Research Corporation, Beckman-Coulter, Inc., Bruker AXS, Inc., Fluid Imaging Technologies, Inc., Micrometrics Instrument Corporation, Horib

Extensive Research on Human Microbiome will Immensely Expand the Awareness of the Composition of Microbial Communities in Human Body

The human microbiome also known as microbiota is composed of population of microbes such as fungi, bacteria and archaea. These microbes reside on the surface or in the deep layers of skin in oral mucosa, the saliva, gastrointestinal tracts and in the conjunctiva. At present, extensive research is being conducted to discover the importance of these micro-organisms in maintaining immune systems and contributing to digestion of food. Large number of microbes resides in the large intestine, with region of the human body having a distinct community of microbes dwelling. For instance, a specific microbial community prefers to grow on the skin or in the nose. Studies are still in progress to understand the factors regulating microbial colonization in areas of the body that are just millimeters apart. The Human Microbiome Project (HMP) was launched in 2008 as a U.S. National Institute of Health. This was initiated with a goal of identifying and characterizing the microbes found within the healthy and diseases human body.

The continuing advancement in biomedical sciences is likely to create opportunities for the application of human microbiome over the next few years. The increasing interest of leading players in mergers and acquisitions is expected to propel this market signifcanlty during the forecast period, notes the market study. In this report, the global market for human microbiome has been studied on the basis of disease, product, application, and region. Geographically, the worldwide market for human microbiome has been segmented into Europe, North America, Asia Pacific and the Rest of the World. North America and Europe have been leading the demand for human microbiome over the recent past and are expected to do so during the forecast period.

The continual improvement in the biotechnological and microbiological research infrastructure has been driving the growth of the human microbiome market in these regions since the last few years. Over the coming years, the mounting risk of lifestyle disorders is likely to propel this market in Europe and North America, states the research report.

Forthcoming Market Structure of Human Microbiome: http://bit.ly/2grcm1M

Based on disease, the report classifies the global market into autoimmune ailments, allergic conditions, diarrhea, obesity, cancer, diabetes, and various other diseases. Based on product, the market has been segmented into probiotics, prebiotics, drugs, devices, and medical foods. Furthermore, the medical food segment has been categorized into oral rehydration products, nutritionally complete formulae, nutritionally incomplete formulae, and formulae for metabolic disorders. Diagnostics and therapeutics have been identified as the two main application areas of human microbiome in this research study.

The leading players in the worldwide human microbiome market are ActoGenix, Enterome Bioscience SA, DuPont, Metabiomics Corp., MicroBiome Therapeutics LLC, Merck & Co. Inc., OptiBiotix Health Plc, Ritter Pharmaceuticals Inc., Osel Inc., Second Genome Inc., ViThera Pharmaceuticals Inc., Vedanta BioScience Inc., and Yakult Honsha Co. Ltd., states the report.

Radiology Information Systems: Measurable Effects of Implementing an RIS are Highly Encouraging

Radiology information systems (RIS) are a part of electronic health record systems and track a patient’s utilization of radiology services throughout a treatment procedure. These days, RIS utilize a software suite, with digitization of the process helping ensure accuracy and minimizing data loss due to manual errors. As a part of hospital information systems, RIS have immensely grown in importance in the last few years and have now become full-fledged components of the overall healthcare industry. Radiology is a vital diagnostic tool for several diseases. Numerous imaging technologies, such as X-ray, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), are included under the umbrella term of radiology and used for the diagnosis of a wide variety of diseases and skeletal conditions such as fractures. Interventional radiology, which consists of carrying out medical procedures with the aid of imaging technologies, is another important part of radiology used in medicine.

The demand for curative and noninvasive diagnostic means is increasing in many regions. This is expected to be the primary reason behind the growth of the global demand for radiology information systems. Radiology depends on numerous electromagnetic processes and thus it does not include incisions. This factor makes radiology a preferable option to the patrons. In many regions, many people are being diagnosed with diseases such as bone disorders and cancer. Radiology is commonly used to diagnose cancer and other disorders, which is a driving factor for the global radiology information systems market.

Obtain the Future Technical Trends of Radiology Information Systems at: http://bit.ly/2gmDWwM

The demand for integrated RIS, especially from the healthcare sector is rising. This trend is also expected to contribute towards the growth of the global radiology information systems market. Integrated RIS are comprehensive in the examination and are more efficient and thus they have beaten standalone RIS. Integrated RIS is predicted to be the largest segment of the global radiology information systems market in the years to come.

As per the findings of the report, mergers and acquisitions of the startup companies will benefit the global market. The rising focus on developed nations for developing healthcare infrastructure is expected to steady the demand for radiology information systems. For a competitive analysis, the global radiology information systems market is geographically divided into North America, Asia Pacific, Europe, and Rest of the World. At present, the global market is led by North America owing to the growing digitization.

Carestream Health, Inc., McKesson Corp., Siemens Healthcare, Philips Healthcare, and GE Healthcare are some of the companies operating in the global market for radiology information systems.

Healthcare Cyber Security: Rise in Patent Infringement Cases and Loss of Patient Health Records Boost its Popularity in the Global Market

Cybersecurity technologies are fast evolving across the globe owing to the changing digital landscape, where security threats are becoming more damaging and smarter. Today, amid the connected health environment, cyber security is not an option, rather it is a compulsion. For every organization, cyber security has become a strategic asset. The healthcare industry is increasingly implementing healthcare IT infrastructure to easily access, send, receive, and manage health care data. The rise in the patent violation cases, medical identity frauds, loss of patient information, and business record breaches are predicted to propel the global healthcare cyber security market in the years to come.

The global healthcare cyber security market has been segmented into solution type, end user and geography. On the basis of the solution type, the healthcare cyber security market has been segmented into risk and compliance management, identity and access management, security information and event management, and intrusion detection system (IDS)/intrusion prevention system (IPS), firewalls, antivirus, antimalware software, data encryption software, and others. The identity and access management is the fastest growing segment in the healthcare cyber security market. The market for end users in segmented into pharmaceuticals & chemicals manufactures, medical devices companies, health insurance companies, hospitals and others. Pharmaceutical companies held the major share of healthcare cyber security market in 2014 and is expected to witness a substantial growth during the forecast period. During the past decade, cyber-attacks on medical device companies, insurance and pharma companies is on the rise, thus fueling the market growth of healthcare cyber security market.

Obtain the Forthcoming Technological Breakthroughs regarding Healthcare Cyber Security at: http://bit.ly/2fDbCEU

Geographically, North America held the largest share of the healthcare cyber security market followed by Europe in 2014, due to the presence of highly developed medical and healthcare infrastructure, high spending on the healthcare information technology, presence of the major pharmaceutical and medical devices companies in the region and government initiatives which have led the growth of the healthcare cyber security market. Asia Pacific is the most attractive market for the healthcare cyber security market due to the rapid improvement in the healthcare industry, economic development in the countries such as China, Japan, India and Australia, which would further booth the healthcare cyber security market during the focus period. Rest of the world holds immense potential for the growth as there are untapped opportunities in the health care cyber security market.

Developing a cyber-security platform is no more an option today, it is a necessity. Some of the major players engaging in the health care cyber security market include Cisco Systems, Inc., IBM Corporation, MacAfee, Inc., Palo Alto Networks, Inc., Symantec Corporation, Lockheed Martin Corporation, FireEye, Inc., Northrop Grumma Corporation, Kaspersky Lab and others.

Choroidal NeoVascularization- Creation of New Blood Vessels in Choroid Layer of Eye: Importance of Choroidal Imaging a New Frontier

Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or due to Age-related Macular Degeneration (AMD). This results in fluid accumulation below the retinal pigment epithelium, which can lead to vision loss or extreme myopic vision among individuals. CNV is also seen in individuals with diabetic retinopathy. In rare cases, it can occur among individuals with defects in Bruch's membrane, the innermost layer of the choroid. It has also been observed by the American Academy of Ophthalmology and other reports that patients with CNV in one eye have a very high probability to contract CNV in the other eye within a short frame of time. According to the British Journal of Ophthalmology published in 2007, age?related macular degeneration (AMD) is one of the leading causes of irreversible sight loss among adults registered as legally blind. Among these, two-thirds of people with AMD have the wet form, which can progress quickly causing irreversible sight loss within days or weeks. In 2007, approximately 250,000 people were suffering from neovascular AMD in the U.K, with an incidence rate of 25,000 and 30,000 new cases annually.

The only successful treatment option that is available commercially in the market for CNVs include intravitreal (direct to the eye) injections of anti-VEGF drugs to control the neovascularization and reduce the fluid accumulated. The most common anti-VGEF compounds are Ranibizumab (Trade name: Lucentis), Bevacizumab (Trade name: Avastin) and the novel drug Pegaptanib (Trade name: Macugen). These drugs belong to a class called anti-angiogenic drugs, their primary objective being the inhibition of the growth of new blood vessels. Anti angiogenic drugs are more commonly used for cancer treatment, where cancerous cells promote angiogenesis resulting in the proliferation of cells in large numbers, thus forming tumors. Bevacizumab is a successfully used cost effective drug for the treatment of cancer as well as AMD related CNVs with a very high half life (more than twice) in comparison with Ranibizumab. However chances of adverse effects with Bevacizumab are comparatively higher, hence Ranibizumab (Lucentis) is now currently the most effectively and safely used treatment for CNV. Pegaptanib on the other hand is in Phase IV of the clinical trials wherein only 1000 patients so far have been treated with significant success rate.

Perceive the Future Details Regarding Choroidal NeoVascularization at: http://bit.ly/2gxDcnM

With increasing aging population throughout the world the probability of occurrence of wet-AMD is high, especially in China and Japan where the aging population is predicted to tip over the young adult population. The patents for both Bevacizumab and Ranibizumab are till 2018 hence after patent expiry it is predicted that their sales shall significantly increase, especially with the entrance of Asian drug manufacturers.

Currently the companies that manufacture Ranibizumab are Novartis (licensed) in global market and Genetech (patented) in the U.S. Bevacizumab too was developed by Roche Pharma in association with Genentech and is currently marketed by Roche internationally. Pegaptanib is manufactured by Eyetch Inc. and marketed by Pfizer Inc.

 Pegaptanib has been approved and is available only in North America, Europe, Brazil and Australia. Ranibizumab is available under the name Lucentis with high market share in Europe and North America and growing in Asia-Pacific region. Bevacizumab is sold as Avastin globally with highest growth rate observed in Asia and highest voluminous growth seen in the North Americas and European markets.  

Agricultural Microbials: Enhances Nutrient Transportation Results in Increased Yield of Plants

Biosynthetic capabilities of microorganisms, in a specific set of environmental condition makes them likely candidates for enhancing nutritional value and pest protection properties in agriculture. Agricultural microbials are produced from naturally occurring microorganisms such as bacteria and fungi. These microbials are usually applied to seeds or sprayed on crops to protect them from pests and diseases. Microbials also enhance productivity and fertility of the plant. Agricultural microbial products provide sustainable and cost effective solutions to increase plant yield, irrespective of geographies. Various types of fungi, bacteria, algae and viruses are the commonly used microbials in agriculture. Furthermore, these microbials play an important role in the production of grains, vegetables, fruits, milk, and poultry and livestock products. Soil is the most important component of agriculture. Microbes present in the soil therefore play a vital role in the management and regulation of nutrients available for crops. Agricultural microbials are thus used to enhance the crop yield. Companies operating in this market are striving to launch products containing different microbial ingredients to meet the expected yield. Agricultural microbials are beneficial in the production of food in the form of a long term sustainable base for agricultural activities that help to maintain and improve human health. Further, agricultural microbials preserve and protect the environment and are therefore beneficial for both farmers as well as consumers. Increasing demand for food is expected to drive the global agricultural microbials market in the next few years. This added factor is expected to boost the market for agricultural microbials in the coming years.

Agricultural microbials supply nutrients such as nitrogen and phosphorus to plants. These microbials also protect plants from pests and diseases. Agricultural microbials enhance the nutrient transportation process, improve soil structure, maintain biological equilibrium and enhance plant growth which subsequently results in increased yield of the plant. Thus, agricultural microbials have become increasingly popular in food production across the globe. Favorable regulatory and financial policies of various governments regarding the usage of microbial products, increasing global population, rising demand for food, and environment-friendly farming practices are the major driving factors of the agricultural microbials market.

Perceive the Agricultural Microbials Market Projections for Upcoming Years at:

http://bit.ly/2go21GG

Growth of the agricultural microbials market is primarily led by the high frequency of crop diseases and rising demand for food in developed as well as developing nations. Environmental protection laws in the U.S. and Europe are major drivers encouraging the use of agricultural microbials in these regions. This trend is likely to continue in the near future with growing importance of the agriculture industry. Furthermore, factors such as innovative production practices that do not harm crop yield would boost the usage of agricultural microbials globally. The market for agricultural microbials is expected to expand in Asia Pacific due to the economic growth coupled with increasing demand for food in the region. Developing countries such as China and India are likely to play a vital role in the agricultural microbials market in coming years due to the increased demand for food. North America, followed by Europe, is anticipated to be the largest market for agricultural antimicrobials due to stringent regulations requiring environment-friendly means of agriculture and rising demand for organic food in the region. Companies operating in this market aim to generate innovative solutions in order to meet the changing need of the consumers and these companies also invest heavily on research and development of new microbial products with the anticipated bright prospects for this market. Therefore, the global agricultural microbials market is anticipated to expand significantly in the near future.

Some of the major companies operating in the global agricultural microbials market are Bayer CropScience AG, Monsanto, BASF SE, Syngent

Major Automobile Manufacturers Boost the Demand of Polymeric Nanoparticles to Develop Light Weight Vehicles and Reduce Carbon Emissions

Polymeric nanoparticles consist of polymers having nanoparticles dispersed in the matrix. This dispersion is done by in-situ polymerization and melt compounding technology which results in enhanced properties of the material. Polymeric nanoparticles possess properties such as high heat resistance, high electrical conductivity and enhanced dimensional stability

The growing application of nanoparticles in various components used in a vehicle such as body panels, engine parts, tires, inner panels of the door, and headlamp covers is driving the growth of the global polymeric nanoparticles market significantly.

Apart from this, the application of polymeric nanoparticles in a wide range of electronic products such as mobile phones, desktops, laptops, and personal data assistants (PDA) is also propelling this market worldwide.

The increasing penetration of smartphones and laptops, stimulated by the rising disposable income of people in emerging economies, is likely to boost the global market for polymeric nanoparticles during the forecast period. The increasing application of these nanoparticles in the pharmaceutical and aerospace industries is also expected to drive the worldwide polymeric nanoparticles market in the coming years, notes the research study.

The report further states that the increase in research and development activities to integrate polymeric nanoparticles into medical devices, as well as drug delivery systems, is projected to present lucrative opportunities to market participants over the forecast period. However, strict regulatory policies associated with the usage of plastic polymers, the complicated production process of nanoparticles, and the high initial investment are expected to hamper the market’s growth considerably in the coming years.

Get the Future Market Predictions for Polymeric Nanoparticles at: http://bit.ly/2g6CiQ7

North America, Asia Pacific, Europe, and the Rest of the world have been identified as the key regional markets for polymeric nanoparticles in this research report. North America, among these, has emerged as the leading regional market in terms of consumption. The U.S. leads the North America polymeric nanoparticles market.

Europe has emerged second in the global market. The increasing demand for light-weight vehicles is propelling the polymeric nanoparticles market in this region.

Over the forecast period, Asia Pacific is anticipated to record the highest growth rate due to the implementation of favorable government policies and the increasing research in the field of nanotechnology, states the research report.

 The report has also studied the competitive landscape present in the worldwide market for polymeric nanoparticles by profiling the key participants in this market. Arkema Group, Cyclics Corp., Elementis Specialties Inc., DSM Somos, Nanoledge SA, Industrial Nanotech Inc., BASF SE, Zyvex Technologies, Cabot Corp., Nanophase Technologies Corp., Nanocor Inc., Inframat Corp., 3M ESPE, Hybrid Plastics, and DuPont are the major players in the global polymeric nanoparticles market, profiled in this study.

Gene Therapy Entails the Use of DNA in the Capacity of a Drug, for the Prevention or Treatment of Diseases

Gene therapy is an experimental therapy that uses genetic modification to treat or avert the risk of diseases. This therapy introduces genetic material in the cells to replace the abnormal genes causing diseases. The intention of this injection can also be to have the body’s immune system create a protein to fight the disease. Currently, gene therapy is an experimental alternative in treating patients, as it has to be validated by medical associations and pharmaceutical companies. This technique still remains under close scrutiny to ensure that it will be a safe and effective method in the realm of disease treatment in the coming years.

The discovery of gene therapy can be traced back to the mid-1970s, when researchers isolated specific genes from DNA for the first time ever. With growing investments and increasing research and development activities, the global gene therapy market has found adequate encouragement in the past few years.

Investments in Gene Therapy to Help Research and Further Data Gathering

As the concept of gene therapy continues to be under microscopic study, there is a growing interest amongst venture capitalists to invest in the commercial aspect of this therapy. The only factor preventing its growth is the huge barrier of regulatory frameworks and approval processes. The majority of gene therapy products or lines of medicine are in phase II or phase III of clinical trial. A large number of these therapies focus on treating various types of cancer and cardiovascular diseases. However, the increasing popularity of DNA vaccines has brought in a positive wave towards gene therapy, making the possibility of practicing it a real one in the near future. Changing perception towards gene therapy will motivate the conductors of phase II and III trials that are already underway, bringing in a new dimension towards treating chronic diseases.

Forthcoming Market Structure for Gene Therapy is available at: http://bit.ly/2fTVFhl

Pros and Cons of Gene Therapy

The global gene therapy market has a score of ethical and legal issues looming over its head. The pros of the method suggest that gene therapy will eliminate genetic diseases, changing the landscape of chronic diseases prevalent in the world today. Furthermore, the research and time invested in studying the intricacies of this therapy will result in creating a databank that will serve as a solution for diseases that are not studied yet. Evidently, gene therapy is a remedy for the future that can create a safety net for coming generations that are at risk from hereditary diseases.

The biggest drawback in the case of gene therapy is its experimental nature, which puts human life at risk in case of its usage. Furthermore, the tremendous cost involved in developing gene therapies is also proving to a tough market restraint. This especially plays a crucial role for patients who need long-term care. The risk involved in the procedure, socioeconomic factors, and poor insurance cover are a few more reasons that are holding this market back.

 Some of the important players in the global gene therapy market are BioSante Pharmaceuticals, AnGes MG, Urigen Pharmaceuticals, Transgene, GenVec, Vical, Genzyme Corporation, and Oxford BioMedica.

Digital Health - Access to Real-Time Healthcare Data and Delivers Effective Healthcare Solutions using IT Tools and Products

Digital health is technology-enabled care that involves the convergence of digital media, health technology, and mobile devices. It is designed to help patients, care givers, and healthcare professionals access relevant data easily and improve the quality of both social and health care. Digital health is gaining impetus since it provides cost-effective solutions at a time when the demand for healthcare services is persistently increasing.

The rising aging population, increasing price of advanced treatments, and shrinking healthcare expenses by governments have impelled healthcare providers to look for complementing solutions to sustain future social and health care systems. Opportunities for deploying mobile technology in a healthcare set-up have significantly increased in the last few years. The proliferation of smart devices and smartphones has played a crucial role in propagating digital health. Notable developments in bio-sensing wearables such as glucose, blood pressure, and diabetes monitors are further expected to augment the interest in digital health.

Digital health enables access to real-time health care data. Furthermore smartphones and wearable medical devices integrating an increasing range of sensors to facilitate monitoring changes in physiology. Therefore, the applicability of digital health is expected to surge extraordinarily in the near future.

The report presents a granular analysis of the global digital health market, studying the various aspects influencing the market’s trajectory between 2016 and 2023. Factors aiding and inhibiting the growth of the market have been analyzed in detail. The report also presents insights into the strategies adopted by various companies operating in the market.

Digital health refers to a system or solution that delivers effective health care solutions using IT tools and products. It is possible to provide better and more efficient care compared to traditional healthcare via patient online services and digital diagnostic techniques. Latest digital health technologies such as electronic health records (EHR), wireless technologies, and digital diagnostic systems encompass data such as patient history, medication, allergies, immunization dates, radiology images, diagnosis, laboratory and tests results, treatment plans, and insurance information.

Obtain the News for Forthcoming Technological Advancement in Digital Health Industry: http://bit.ly/2frb1WS

The global digital health market is exhibiting robust growth due to the increasing demand for advanced information systems in the health care industry. Favorable policies by governments and the rising investment by players in the healthcare information system (HIT) have also been aiding the expansion of the digital health market. Additionally, the market is also gaining impetus from the growing demand for remote monitoring services in response to the proliferation of home healthcare services.

On the flip side, certain restraints often associated with the global digital health market include high capital expenditure, privacy and security issues, expenditure incurred on maintenance requirement, and inadequate infrastructure of the healthcare industry in developing countries.

Regionally, North America dominates the global digital health market and is expected to maintain its dominance through the forecast period. This exponential surge witnessed by the regional market is aided by the developed healthcare infrastructure, increased healthcare spending, and the increasing incidence of chronic illnesses in the region.

 The digital health market is also witnessing attractive opportunities in Europe. The European market is primarily aided by the increasing geriatric population, rising prevalence of chronic ailments, and technological advancements introduced in the HIT. However, during the forecast period, the Asia Pacific digital health market is expected to report growth at highest rate. The increasing investment in healthcare and IT will support the growth of the digital health market in Asia Pacific. To present insights into the competition prevailing in the market, the report also profiles companies such as General Electric Company, AT&

Vascular Stents: Cardiac Surgeons Prefers to Use Vascular Stents in Place of Balloon Angioplasty

Vascular stents are tiny wire mesh tubes placed into blood vessels, arteries or other hollow structures to open the blockage of vessels. The process for placement of vascular stent into body is known as vascular stenting. Vascular stenting is considered as a valuable tool for applications of non-coronary vasculature. These stents are used to open narrowed vessels and reduce the chances of chest pain or heart attack. Most of the stents are made up of metal or plastic mesh like materials. There are commonly two types of stents namely bare metal stents and covered stents, also called as stent grafts.

The rising aging population will be a major driving factor for the global vascular stents market, state the analysts. As per the findings of the World Health Organization (WHO), in 2000 there were 605 million people aged 65 years or more. The number is projected to reach 2 billion by 2050. Additionally, technological advancements in medical devices are anticipated to propel the global market for vascular stents.

Vascular stents have taken over the conventional surgical methods due to their advantages such as short recovery time, minimized bleeding, minimal risk of infection, and low cost. However, manufacturers of vascular stents are predicted to face the biggest challenge of the availability of alternative therapies.

The report segments the global vascular stents market on the basis of region and material. Metal stents, biodegradable polymeric stents, and standard polymeric stents are the primary types of vascular stents.

Obtain the Future Market Projections for Vascular Stents at: http://bit.ly/2gJdLoi

By geography, the global vascular stents market is divided into Europe, Asia Pacific, North America, and Rest of the World. Currently, North America leads the global market for vascular stents owing to the rising number of people suffering from cardiovascular diseases. Europe follows North America to be the second largest market for vascular stents. The rising preference of surgeons to use newly introduced vascular stents to treat cardiovascular diseases will propel the vascular stents market in Europe, predict the analysts. Increasing government funding in China, India, and South-East Asia is projected to propel this market in Asia Pacific.

 The research evaluates company profiles of leading participants operating in this market to present a competitive landscape. Some of the prominent players listed in the report are Cook Medical, InnoCore Technologies BV, Cordis Corporation, MIV Therapeutics Inc., Boston Scientific Corporation, Translumina GmbH, Stentys SA, SurModics Inc., Xtent Inc., Goodman Co. Ltd., Abbott Laboratories, Biosensors International Ltd., Reva Medical Inc., MicroPort Scientific Corp., Allvivo Vascular Inc., and Medtronic, Inc.

Protein Expression: Biotechnology based Organizations Mostly rely on Protein Expression for Developing Novel Therapeutics with Minimal Side Effects

Protein expression is a technique in which proteins are effectively regulated, modified, as well as synthesized in living organisms. Protein expression is an essential element of proteomics. Proteins are regulated, modified, and synthesized on the basis of the functional needs of the host cell. Protein expressions include three processes: translation, transcription, and post-translational modification. There are three kinds of recombinant protein expression techniques, including in-vitro protein expression, chemical protein synthesis, and in-vivo protein expression. The increasing number of opportunities in proteomics and the growing research activities, especially in the pharmaceutical industry, will propel the global protein expression market in the years to come.

On the basis of host system, the global protein expression market is classified into yeast expression, mammalian expression, algae expression, insect expression, cell-free expression, and bacterial expression. By application, the global protein expression market is classified into cell culture, membrane proteins, transfection technologies, and protein purification. Some of the end users in the global protein expression market are drug discovery contract research organizations, pharmaceutical companies, and academics.

The growing use of protein expression in the manufacture of biotechnology products is one of the primary factors expected to propel the global protein expression market in the years to come. The increasing developments in the biotechnology and proteomics industry are predicted to propel the global market for protein expression. The high success rate of the use of biotechnology-based therapeutic products might significantly boost the global protein expression market in the long run. Based on region, the global protein expression market is divided into Asia Pacific, Europe, North America, and Rest of the World. At present, North America leads the global protein expression market, followed by Europe.

Get the Prospective for the Future Market Trends of Protein Expression at: http://bit.ly/2geDW1c

However, Asia Pacific is expected to be the emerging market in the near future. The development initiatives taken by several emerging economies are predicted to propel the Asia Pacific protein expression market throughout the forecast period. Expected technological advancements are predicted to create many opportunities for monitoring cellular response, determining genetic predisposition, and targeted pain receptors, which are predicted to drive the global protein expression market. Stringent approval policies and the high cost linked with research and development activities are two of the factors expected to restrict the growth of the global protein expression market.

Some of the leading companies in the global protein expression market are Agilent Technologies, Inc., EMD Millipore, Oxford Expression Technologies Ltd., Thermo Fisher Scientific Inc., and Life Technologies Corporation. Mergers and acquisitions with new entrants are predicted to assist the leading players in maintaining their dominance in the global protein expression market in the coming few years.

Intraocular Lens: Choosing the Best IOL For Cataract Surgery

Intraocular lens (IOL) is inserted in the eyes of the patients suffering from myopia or cataracts. The lenses are inserted inside the eye, after removal of cataract crystalline. After the cataract surgery intraocular lens replaces the focusing power of natural lens. The pseudophakic intraocular lens (PIOL) switches with original crystalline lens to deliver the light focusing function which was originally undertaken by crystalline lens. Another type of IOL named phakicis is placed over the existing natural lens. This type of lens is used in refractive surgery to increase the optical power of an eye as a treatment for myopia or nearsightedness. IOL consists of minor plastic lens with plastic struts named haptics. Cataract or myopia vision can be restored by three methods. The first method is use of glasses to restore vision. The second method is to wear a contact lens to correct myopia or cataract vision. Third method describes placement of permanent intraocular lens inside the eye.

The global market for intraocular lens can be segmented as follows:

By materials

> Poly(methyl methacrylate)

> silicone

> hydrophobic acrylate

> hydrophilic acrylate

> collamer

By product types

> Aphakic

> Pseudophakic

> Phakic

Geriatric population is at high risk of suffering from myopia or cataract. Thus, with rapid increase in geriatric population the global market for intraocular lens is also expected to grow. In addition, technological advancements in intraocular lens market also further accentuate the market growth. Moreover, rising adoption of premium intraocular lens such as multifocal IOLs, toric IOLs and accommodating IOLs are further accentuating the global market for intraocular lenses during the forecast period. However, high cost associated with surgical procedures for the placement of intraocular lens inside the eye might restrict the global market of intraocular lens. In addition, post operative refractive error might be a crucial concern that can pose serious threat for the demand of intraocular lens market.

Extract the Forthcoming Market Information for Intraocular Lenses at: http://bit.ly/2fnGSb6

North America dominates the global intraocular lens market owing to large number of cataract surgeries performed every year. For instance, Society of Cataract and Refractive Surgery (ASCRS) estimated that around 3 million cataract surgeries are performed in the U.S. every year. In addition, government initiatives and favorable reimbursement scenario also drives the growth of intraocular lens market in North American region. Moreover, technological advancements in intraocular lens surgical procedure also further accentuates the global market for intraocular lens during the study period. Europe represents the second position in the global market of intraocular lens due to the presence of large geriatric population in European region. In addition, initiatives taken by government for the benefit of people to perform cataract surgery also propel the growth of intraocular lens market in this region. Asia-Pacific and RoW represents the third and fourth position in the global market for intraocular lens due to lack of proper healthcare facilities (refractive surgery) in few remote areas of Asian (India, Bangladesh, Pakistan) and African countries (Egypt, Libya, Sudan). Moreover, high cost of performing cataract surgery is a barrier for intraocular lens market growth in the developing and underdeveloped countries in the world especially in Asian and African continent.

 Various key players contributing the global market share of intraocular lens market includes Abbott Medical Optics, Carl Zeiss, Bausch & Lomb, Eyekon Medical, Lenstec, Humanoptics, Novartis AG, Morcher GmbH, Ophtec BV, Oculentis BV, Ophtec USA, PowerVision, Physio SA, Rayner Intraocular Lenses, Staar Surgical Company, Santen Pharmaceutical and Wavelight AG among others.  

Wearable Medical Technology Becomes Less Gimmicky and Readies for Serious Implementations

The proliferation of wearable technologies into a field based on necessity, i.e. the healthcare industry, has been a long awaited move. Current variants of commercially available – and financially viable for the majority – wearable tech includes fitness tracking wristwatches and the likes. The healthcare industry has bigger plans for wearables and is already on the way to help people from all walks of life gain functional and increasingly useful tech that can help them live better. The modern wearable medical technologies are aimed at helping the elderly, the athletes, the disabled, and the chronically sick to perform daily tasks while not getting in their way.

Industry experts from Transparency Market Research have evaluated the global wearable medical technologies market to quantify its imminent future progress rate. To explain the analysis, the analysts have answered three question crucial to grasping the market dynamics.

What are Some of the more Commercialized Medical Wearables?

The most common use of medical wearable comes in various forms of wrist bands or watches. We have, for instance the wristbands integrated with Near Field Communication that allow a nearby scanning device to tag the band and receive an individual’s medical data. Other wrist band types may allow a patient to check their pulse, their sleep patterns, a fall or an accident, and even sleepwalking. The bands can alert the user to take their medicine on time, or alert medical personnel, hospitals, and close ones of any incident that may have occurred.

In fact, most of the wearable medical devices are a result of the convergence of conventional medical devices with portable consumer electronics. This will give us a much clearer perspective on how the global wearable medical technologies market is expected to progress in the near future.

Perveive Huge Perspective for the Future Market of Wearable Medical Technology at: http://bit.ly/2gfnO0X

What Other Aspects of Modern Electronics are Incorporated in Medical Wearables?

Essentially, all technologies in consumer electronics can be utilized to improve the devices in the global wearable medical technologies market. For instance, the integration of the Internet of Things (IoT) can be extremely helpful in creating a secure connected environment for a patient within a small space. The connected devices can help the patient perform daily functions without human assistance, order for prescription drugs and pay for them online, keep a record of their health, and most importantly, allow medical personnel to remotely monitor them.

Are There Any Immediate Concerns to the Global Wearable Medical Technologies Market?

There are quite a few concerns, the most pressing of which is user safety and measurement accuracy. Device safety standards and testing may be, however rarely, lacking in a definitive set of guidelines to dictate the terms of use. Most policies, such as the U.K., Medicines and Healthcare Products Regulatory Agency’s policy, is to establish the responsibility of safety directly on the manufacturer. The agency has clearly stated in its guidelines that the manufacturers need to use a proper set of controls on the device to ensure the most safe user experience.

As for accuracy, it’s a two way street. Common lifestyle and fitness devices need a certain set of data inputs that need to be accurately fed to receive the right results. One of the biggest problems most users face is that these devices can be inaccurate at times. And the repercussions of a wrong reading can be increasingly severe when performed by medical wearables that are used by, say, cancer patients or the chronically ill.

 These issues must be addressed properly in order to ensure a smooth growth trajectory for the global wearable medical technologies market.

Telehealth - A Cost Effective Service which Reduces the Number of Patient Visits thus Saving Time

Modern world is shifting from the age old concept of conventional medical treatment to technologically well-equipped treatment services. Thus the concept of telehealth services is gaining attention. In telehealth service there is an exchange of remote data between the patient at home and their doctor(s) to assist in diagnosis and monitoring patients with long term ailments. Among other techniques it includes fixed or mobile home units to measure, analyze and monitor body temperatures, blood pressure, sugar level and various other vital parameters for clinical evaluation at a remote location by using phones or wireless medium. Telehealth services have increase awareness among the individuals about their own health assisting both the patients and the doctors. Telehealth is advantageous in a way that it reduces the number of patient visits, thus saving time and also is a very cost effective service and thus can be availed by a large number of population.

Doctors and clinicians, by this service can constantly monitor and guide the patient about their long term ailment, ultimately reducing the mortality rate. Moreover, it has also lead to drastic decrease in incidences of emergency admission. This has changed the perception of conventional medical practice, which forms the major driver for the market. Telehealth is not only restricted to long term ailments, but also has a wide range of applications like dentistry, counselling, physical and occupational therapy, disaster management and consumer and professional education.

The rate of using telehealth services is influenced by many factors such as the availability and cost of existing conservative health services in meeting patient requirements; the requirement of medical licensing, the policies of governments with respect to coverage, and payment for telehealth services. Modern techniques are being administered in telehealth service market like store-and-forward method, real-time, remote patient monitoring, remote training, and electronic consultation. With the use of all these techniques, telehealth service market is gaining popularity.

Obtain the Future Market Structure of Telehealth Services at: http://bit.ly/2fAaCSO

The global telehealth services market is segmented on the basis of end user, type, application, and geography. Clinical and non-clinical are sub-segments of the type segment. Clinical uses comprise diagnosis of disease, disease management, advice on prevention from diseases, promoting good health, and using telephonic medium to deal with emergency situations. Non-clinical uses of telehealth services include distance education, movement of patient and remote admission, research programs on telehealth services, health data management, and providing online information.

On the basis of application, the market is segmented into dermatology, cardiology, gynecology, neurology, and orthopedics. The global telehealth services market is segmented on the basis of end user into telehome, telehospital, assisted living, worried well living, and facility. On the basis of geography, the telehealth services market is segmented into Latin America, North America, Asia Pacific, Europe, and Rest of the World.

 Key players operating in the global telehealth services market, which have been included in the report for the purpose of study are: LifeWatch AG, Allscripts Healthcare Solutions, Inc., McKesson Corporation, CARDIOCOM, LLC, Polycom, Inc., F. Hoffmann-La Roche Ltd., AMD Global Telemedicine, Inc., Cisco Systems, InTouch Technologies, Inc., Philips Healthcare and Honeywell HomMed LLC.

Bone and Joints Ingredients: Calcium an Established Ingredient with a Mature Market

Bone and joints ingredients are supplements developed to enhance the condition of bones and joints of a human body. These health supplements strengthen the bones by supplementing it with soy isoflavone, calcium, and collagen. Besides these, the popularly available ingredients in the global bone and joints ingredients market are chondroitin and glucosamine. A regular intake of these ingredients helps in maintaining a healthy bone mineral density (BMD), which in turn prevents bone loss.

The analysis indicates that the global bone and joints ingredients market has been growing at a remarkable pace due to the exponentially rising pool of geriatrics across the globe. The weakening of bone and joints due to aging often leads to impaired movements and aches. Furthermore, it also makes the body susceptible to fractures and other disorders such as arthritis, back and neck pain, injuries, and osteoporosis. Increasing expenditure on sports nutrition is also driving this market as nutritionists are focusing on strengthening the bones and joints of players to prevent sports injuries.

This biggest restraint for the global market is the reported possibility of diseases such as cancer and cardiovascular diseases due to overconsumption of these ingredients. However, companies are trying to develop ingredients that are safer than the ones that are available. Furthermore, the introduction of medications that reduce the inflammation of joints for arthritis paints and also hold the promise of curing the symptoms are posing a tough challenge for the market. To worsen the situation further, the market is also being hampered by strict regulatory laws and other procedures to obtain approvals.

Obtain the Future Predictions for the Industry of Bone and Joints Ingredients at: http://bit.ly/2fXz29A

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

The chief operating players in the global bone and joints ingredients market BASF SE, Archer Daniels Midland (ADM), DuPont and Royal DSM NV. The research report studies the management styles of these companies along with evaluating the competitive landscape of the overall market. To explain the trajectory of this market, analysts have listed the research and development activities of these companies, their financial overview, business and marketing strategies, and expansion plans for the near future.

n-Dimensional Image Processing and Visualization is the Major Growth Factor for Medical Image Analysis Software Demand

The collaborative work of medical experts and technology experts have given the world a range of equipment that enables accurate diagnoses of diseases and customized therapy for the same. Medical imageanalysis software is a part of these innovations and allows quantitative visualization and analysis of various medical images gathered using a spectrum of medical devices such as SPECT, PET, MRI, CT, ultrasound, and X-ray. The rising affordability of these instruments has enabled medical experts to make a quantitative analysis and process enhanced biomedical images that bring about higher efficiency in treatments offered to the patient.

Medical Image Analysis Software Offers an Edge to Medical Experts with Accurate Medical Data

The biggest help medical image analysis software provides is the computation of vast medical data with its efficient methods and algorithms. The global medical image analysis software market has witnessed a great growth rate as medical practitioners have gained the added advantage of gathering accurate medical data to customize treatments. Additionally, medical experts can also treat patients in remote locations with medical image analysis software, thereby improving the quality of life and reducing mortality in patients.

North America to Lead Global Medical Image Analysis Software Market

The global medical image analysis software market is segmented on the basis of imaging modalities, end users, and geography. On the basis of imaging modalities, the global medical image analysis software market has been segmented into magnetic resonance imaging (MRI), positron emission tomography (PET) and single photon emission computed tomography (SPECT), computed tomography (CT), X-ray, ultrasound, and microscopy. Based on end user, the global medical image analysis software market is segmented into diagnostic centers and general hospitals. Geographically, this market has been segmented into Europe, North America, Asia Pacific, and Rest of the World.

Perceive the Future Market Forecast of Medical Image Analysis Software at:

http://bit.ly/2fJtKkb

According to industry experts, North America holds a leading position in the global medical image analysis software market, with Europe following closely. The key market drivers for these regions are the rapid advent of technological advancements and a need for multi-dimensional platforms in image processing and visualization. In addition to these growth drivers, the growing demand for diagnostic procedures, which comes with tremendous support for innovations therein, will fuel the growth of the global medical image analysis software market.

Innovations to Dictate the Future of Companies in the Global Market

The global medical image analysis software market is restricted due to lack of trained manpower to handle the complex equipment and expensive medical software, especially in developing nations.

 The global medical image analysis software market is a highly competitive one. In the near future, success in developing and marketing innovations and novel technologies will decide the fate of the market players. Manufacturers of medical image analysis software will have to devise a technologically advanced range of software to retain significance in the market. Some of the key players to watch out for in the global medical image analysis software market are Philips, GE Healthcare, Spacelabs Healthcare, Agfa Healthcare, EsaoteSpA, Claron Technologies, Toshiba Medical Systems, Xinapse Systems Ltd., and Siemens AG.